期刊文献+

具核梭杆菌促进结直肠癌发生发展机制研究进展

Research progress in mechanism of Fusobacterium nucleatum promoting colorectal cancer
下载PDF
导出
摘要 具核梭杆菌(Fusobacterium nucleatum)是一种人体共生菌,尤其富集于口腔,在特定情况下可导致机会感染。近年来,随着微生物群与健康或疾病相关性研究的深入,具核梭杆菌与结直肠癌(colorectal cancer,CRC)之间的关联性研究备受关注。大量临床研究表明,具核梭杆菌在CRC中更为富集,且进一步的动物研究证明具核梭杆菌能够通过多种机制促进CRC的发生发展以及肿瘤耐药。本文对具核梭杆菌与CRC的关联性以及其对CRC的发生发展机制进行综述。 Fusobacterium nucleatum,a commensal bacterium in human oral cavity could cause opportunistic infections in certain conditions.Recently,the relationship between Fusobacterium nucleatum and colorectal cancer(CRC)has become a research focus.Clinical studies revealed that Fusobacterium nucleatum is implicated in CRC.Further studies on animals have proved that Fusobacterium nucleatum can promote the onset and progression of CRC and chemoresistance to treatments.This paper summarizes evidence for the association of Fusobacterium nucleatum with CRC and provides a comprehensive view of current mechanisms for the association.
作者 陈子贤 敦译霆 刘畅 陈倩 CHEN Zixian;DUN Yiting;LIU Chang;CHEN Qian(Shanghai Jiao Tong University School of Medicine,Shanghai 200025)
出处 《微生物与感染》 CAS 2021年第2期123-128,共6页 Journal of Microbes and Infections
关键词 具核梭杆菌 结直肠癌 肿瘤微环境 致病机制 Fusobacterium nucleatum Colorectal cancer Tumor microenvironment Mechanism research
  • 相关文献

参考文献4

二级参考文献138

  • 1Federica Zoratto,Luigi Rossi,Monica Verrico,Anselmo Papa,Enrico Basso,Angelo Zullo,Luigi Tomao,Adriana Romiti,Giuseppe Lo Russo,Silverio Tomao.Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis[J]. Tumor Biology . 2014 (7)
  • 2Schwabe RF, Jobin C. The microbiome and cancer. Nat RevCancer 2013; 13: 800-812 [PMID: 24132111 DOI: 10.1038/nrc3610].
  • 3Dickson RP, Martinez FJ, Huffnagle GB. The role of themicrobiome in exacerbations of chronic lung diseases.Lancet 2014; 384: 691-702 [PMID: 25152271 DOI: 10.1016/S0140-6736(14)61136-3].
  • 4Kahn SE, Cooper ME, Del Prato S. Pathophysiology andtreatment of type 2 diabetes: perspectives on the past, present,and future. Lancet 2014; 383: 1068-1083 [PMID: 24315620 DOI:10.1016/S0140-6736(13)62154-6].
  • 5Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology--analysis of host and tumor factors for personalized medicine. NatRev Clin Oncol 2011; 8: 711-719 [PMID: 21826083 DOI: 10.1038/nrclinonc.2011.122].
  • 6Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassengermodel for colorectal cancer: beyond the usual suspects.Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI:10.1038/nrmicro2819].
  • 7Signat B, Roques C, Poulet P, Duffaut D. Fusobacteriumnucleatum in periodontal health and disease. Curr Issues Mol Biol2011; 13: 25-36 [PMID: 21220789].
  • 8Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, GroteVA, Tjneland A, Dahm CC, Overvad K, Jenab M, Fedirko V,Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R,Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D,Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD,Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E,Dorronsoro M, Quir JR, Duell EJ, Ye W, Sund M, Lindkvist B,Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Buenode-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria andrisk of pancreatic cancer in a large European prospective cohortstudy. Gut 2013; 62: 1764-1770 [PMID: 22990306 DOI: 10.1136/gutjnl-2012-303006].
  • 9Michaud DS. Role of bacterial infections in pancreatic cancer.Carcinogenesis 2013; 34: 2193-2197 [PMID: 23843038 DOI:10.1093/carcin/bgt249].
  • 10Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N.Induction of experimental ulcerative colitis by Fusobacteriumvarium isolated from colonic mucosa of patients with ulcerativecolitis. Gut 2003; 52: 79-83 [PMID: 12477765].

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部